Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001213900-23-073551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-05 | 2023-09-01 | CVKD | Pham Quang X | CEO, COB, Dir, 10% | P - Purchase | $0.9129 | +70.0K | 3.35M | +2% | +$63.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | P | A | 10,000 | $0.93 | 3,310,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | P | A | 10,000 | $0.84 | 3,370,000 | D | — | — | |
| 3 | Common | Common Stock | 2023-09-01 | P | A | 10,000 | $0.92 | 3,360,000 | D | — | — | |
| 4 | Common | Common Stock | 2023-09-01 | P | A | 20,000 | $0.93 | 3,330,000 | D | — | — | |
| 5 | Common | Common Stock | 2023-09-01 | P | A | 20,000 | $0.92 | 3,350,000 | D | — | — |